Explore Contact Sales BookLogin Sign Up

Content

All Content
Interviews
Companies
Business Models
Moats
IP ResearchValue Chains, Company Profiles, Research Analysis
IP Research OfferingUpcoming Coverage
IP ReferencesManagement Reference Checks

Free Content

IP Fieldwork PodcastA lens into how we approach primary research
Weekly UpdatesNewsletter with insights and analysis of the newest research
Content IndexAll content by company
Listen to In PractiseConnect to Spotify, Apple, and more

Explore our full content library.

Found 2 results in 1ms

Found 2 results in 1ms

AGC Biologics & Western vs Chinese CDMOs

Executive at AGC Biologics

Partner Interview

AGC BiologicsWuXi BiologicsBayerLonza GroupThermo Fisher ScientificSartorius Stedim BiotechMerckPfizerCatalentSwitching CostsMission Critical Products & ServicesOEMs w/ Installed BaseHealth Care

Lonza, WuXi Biologics & CDMO Global Market: Competitive Landscape Evolution

Executive at AGC Biologics

Partner Interview

Lonza Group•CH•Large CapPfizerEli Lilly andNovo NordiskRocheWuXi BiologicsAGC BiologicsHealth Care

You've reached the end

Footer

Quality Primary Research for Long-Term Investors

Join our community on X!Join our community on LinkedIn!Contact us if you have any questions. We are happy to help.RSS and Podcast Feed

Account

Reset Password
Signup
Login
For Executives
Refer Executives

Compliance

Compliance Policy
Executive Terms of Engagement
Privacy
Terms and Conditions of Use

Services

Explore content
Ownership Tracker
RSS and Podcast feed
Partner
Partner FAQs
DBS Program

About

About our story and team
Limited Edition Book
Careers
Two-minute Feedback Survey
Frequently Asked Questions

© 2026 IP1 LTD. All rights reserved.